Level Biotechnology Inc. (TPEX:3118)
Taiwan
· Delayed Price · Currency is TWD 33.75
+0.20 (0.60%)
Apr 29, 2026, 1:21 PM CST
Level Biotechnology Market Cap
Level Biotechnology has a market cap or net worth of 1.09 billion as of April 29, 2026. Its market cap has decreased by -1.90% in one year.
Market Cap
1.09B
Enterprise Value
886.43M
Revenue
736.59M
Ranking
n/a
PE Ratio
13.75
Stock Price
33.75
Market Cap Chart
Since November 3, 2004, Level Biotechnology's market cap has increased from 249.68M to 1.09B, an increase of 336.07%. That is a compound annual growth rate of 7.09%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Advance Bio-Pharmaceutical | 1.07B |
| GeneReach Biotechnology | 1.13B |
| Lukas Biomedical | 1.01B |
| TCI GENE | 1.01B |
| BiOptic | 1.20B |
| Holy Stone Healthcare | 1.20B |
| NatureWise Biotech & Medicals | 897.75M |
| Abnova (Taiwan) | 1.35B |